Image-based screening: a technology in transition.
Image-based screening (IBS) has proven itself with whole-well assays in which throughput and assay miniaturization are priorities. Recent interest, however, has centered upon the use of automated imaging technology to conduct assays at subcellular resolution. These in vitro assays have the potential to increase lead quality at early stages in drug discovery. Subcellular IBS is not yet mature and, although some assays provide reliable data at reasonable throughput, many others have yet to demonstrate robust application. Developments in image acquisition, analysis and informatics technologies are ongoing and are expected to broaden the usefulness of subcellular IBS.
Ramm
Peter
P
Invicta Research Inc., 290 Riverview Boulevard, St Catharines, ON L2T 3N4, Canada. Peter.Ramm@invictaresearch.com
D001709:Biotechnology / Q000379:methods* / Q000639:trends; D004353:Drug Evaluation, Preclinical / Q000379:methods* / Q000639:trends; D007090:Image Interpretation, Computer-Assisted / Q000379:methods*; D046228:Microarray Analysis / Q000379:methods* / Q000639:trends; D008856:Microscopy, Fluorescence / Q000379:methods* / Q000639:trends; D025941:Protein Interaction Mapping / Q000379:methods* / Q000639:trends